These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 22748558
1. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma. Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A. Eur J Radiol; 2012 Nov; 81(11):3002-9. PubMed ID: 22748558 [Abstract] [Full Text] [Related]
6. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy. Toyoda H, Kumada T, Tada T, Niinomi T, Ito T, Sone Y, Kaneoka Y, Maeda A. J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360 [Abstract] [Full Text] [Related]
7. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. Golfieri R, Grazioli L, Orlando E, Dormi A, Lucidi V, Corcioni B, Dettori E, Romanini L, Renzulli M. J Magn Reson Imaging; 2012 Sep; 36(3):648-57. PubMed ID: 22592930 [Abstract] [Full Text] [Related]
8. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation. Lee S, Kim SH, Park CK, Kim YS, Lee WJ, Lim HK. J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073 [Abstract] [Full Text] [Related]
9. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience. Lee SA, Lee CH, Jung WY, Lee J, Choi JW, Kim KA, Park CM. Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227 [Abstract] [Full Text] [Related]
10. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. Asayama Y, Tajima T, Nishie A, Ishigami K, Kakihara D, Nakayama T, Okamoto D, Fujita N, Aishima S, Shirabe K, Honda H. Eur J Radiol; 2011 Dec; 80(3):e243-8. PubMed ID: 21109378 [Abstract] [Full Text] [Related]
11. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma. Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kawai K, Kozaka K. J Comput Assist Tomogr; 2011 Dec; 35(2):181-6. PubMed ID: 21412087 [Abstract] [Full Text] [Related]
12. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW. AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994 [Abstract] [Full Text] [Related]
14. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM, Kim SH, Kim YK, Choi D. Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [Abstract] [Full Text] [Related]
15. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Granito A, Galassi M, Piscaglia F, Romanini L, Lucidi V, Renzulli M, Borghi A, Grazioli L, Golfieri R, Bolondi L. Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022 [Abstract] [Full Text] [Related]
16. Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN. Eur J Radiol; 2012 Dec; 81(12):3877-82. PubMed ID: 22954410 [Abstract] [Full Text] [Related]
18. Application of classification trees for the qualitative differentiation of focal liver lesions suspicious for metastasis in gadolinium-EOB-DTPA-enhanced liver MR imaging. Schelhorn J, Benndorf M, Dietzel M, Burmeister HP, Kaiser WA, Baltzer PA. Rofo; 2012 Sep; 184(9):788-94. PubMed ID: 22618476 [Abstract] [Full Text] [Related]